Skip to Content
Merck
  • Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.

Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.

The American journal of pathology (2006-08-01)
Seiji Goda, Hiroshi Inoue, Hisanori Umehara, Michihiko Miyaji, Yutaka Nagano, Nari Harakawa, Hisao Imai, Peter Lee, James B Macarthy, Takashi Ikeo, Naochika Domae, Yoji Shimizu, Joji Iida
ABSTRACT

Natural killer (NK) cells play a key role in inflammation and tumor regression through their ability to migrate into tissues. CXCL12 is a chemokine that promotes lymphocyte invasion and migration into tissues; however, the mechanism for this process remains incompletely understood. In this study, we show that CXCL12 significantly enhanced CD16(+)CD56(+) human peripheral NK-cell invasion into type I collagen by the catalytic activity of matrix metalloproteinase-1 (MMP-1). Confocal immunofluorescence and co-immunoprecipitation studies suggest that MMP-1 colocalized with alpha(2)beta(1) integrin on CXCL-12-stimulated NK-cell surface. The binding of pro-MMP-1 with alpha(2)beta(1) integrin required activation of G(i)-coupled pathway. However, the production of MMP-1 from CXCL12-stimulated NK cells was mediated by p38 and mitogen-activated or extracellular signal-regulation protein kinase kinase 1/2 in a manner independent of the G(i)-coupled pathway. These results suggest that CXCL12/CXCR4 interaction transduces the two signaling pathways to promote NK-cell invasion, which stimulates pericellular degradation of extracellular matrix proteins by membrane-associated MMP-1. The mechanisms would thus play a role in facilitating lymphocyte trafficking and accumulation in tissues during physiological and pathological processes.